On April 21, 2026, the day after the application deadline for Medicare Part D plan sponsors to participate in the BALANCE Model, CMS announced that it would not be moving forward with implementation of the BALANCE Model in Medicare in 2027 and instead would be extending the Medicare GLP-1 Bridge to run through the end of 2027
The weight loss trajectory at week 37-48 is beginning to decelerate, which is physiologically normal and expected
Lifestyle support: Am I protecting protein intake, muscle, hydration, and mental health
Both disproportionality analyses confirmed this heightened risk: ROR analysis showed a statistically significant association (ROR = 1.81, 95% CI 1.622.03), while BCPNN yielded an information component of IC = 0.85 (IC025 = 0.69), both indicating substantially greater renal impairment risks in this older population treated with the combination therapy
Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing
One recurring fee is meant to fold together the virtual evaluation, the written prescription, and pharmacy fulfillment of compounded semaglutide or tirzepatide